Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
indakaterooli kasutamise kohta rasedatel ei ole andmeid.
there are no data from the use of indacaterol in pregnant women available.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
hirobriz breezhaler on ravim, mis sisaldab toimeainena indakaterooli.
hirobriz breezhaler is a medicine that contains the active substance indacaterol.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
indakaterooli kontsentratsioon seerumis suurenes korduval üks kord päevas manustamisel.
indacaterol serum concentrations increased with repeated once-daily administration.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
cyp3a4 loetakse põhiliseks isoensüümiks, mis vastutab indakaterooli hüdroksüülimise eest.
cyp3a4 is concluded to be the predominant isoenzyme responsible for hydroxylation of indacaterol.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
in vitro uuringutes on ugt1a1 isovorm peamine indakaterooli metabolismi vahendaja.
in vitro the ugt1a1 isoform is a major contributor to the metabolic clearance of indacaterol.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
indakaterooli püsikontsentratsioon saabus 12...15 päeva jooksul üks kord päevas manustamisel.
steady state concentrations of indacaterol were achieved within 12 to 15 days following once-daily administration.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
indakaterooli renaalne kliirens oli keskmiselt 0,46...1,20 liitrit/tunnis.
renal clearance of indacaterol was, on average, between 0.46 and
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
indakaterooli fenool-o-glükuroniid ja hüdroksüülitud indakaterool olid teised peamised metaboliidid.
phenolic o-glucuronides of indacaterol and hydroxylated indacaterol were further prominent metabolites.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
4764 patsienti said indakaterooli kuni ühe aasta jooksul maksimaalsest soovitatavast annusest kuni kaks korda suuremates annustes.
4,764 patients were exposed to indacaterol up to one year at doses up to twice the maximum recommended dose.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
indakaterooli maksimaalse kontsentratsiooni saabumise aeg seerumis oli umbes 15 min pärast ühekordsete või korduvate inhaleeritavate annuste manustamist.
the median time to reach peak serum concentrations of indacaterol was approximately 15 min after single or repeated inhaled doses.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
on teatatud kohestest ülitundlikkusreaktsioonidest pärast indakaterooli või glükopürrooniumi manustamist, mis on ultibro breezhaler’i koostisosad.
immediate hypersensitivity reactions have been reported after administration of indacaterol or glycopyrronium, which are components of ultibro breezhaler.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kliinilistes uuringutes oli muutumatul kujul uriiniga eritunud indakaterooli kogus üldjuhul alla 2,5% manustatud annusest.
in clinical studies, the amount of indacaterol excreted unchanged via urine was generally lower than 2.5% of the delivered dose.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
olemasolevad farmakokineetilised/toksikoloogilised andmed on näidanud indakaterooli, glükopürrooniumi ja nende metaboliitide eritumist lakteerivate rottide piima.
available pharmacokinetic/toxicological data have shown excretion of indacaterol, glycopyrronium and their metabolites in the milk of lactating rats.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
indakaterooli beeta-2-agonistlikest omadustest tingitud toimed kardiovaskulaarsüsteemile olid tahhükardia, arütmiad ja müokardi kahjustus koertel.
effects on the cardiovascular system attributable to the beta2-agonistic properties of indacaterol included tachycardia, arrhythmias and myocardial lesions in dogs.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
in vitro uuringud näitasid, et oodatav kopsu jõudva indakaterooli annus on sarane ultibro breezhaler’i ja indakaterooli monoteraapia puhul.
based on the in vitro performance data, the dose of indacaterol delivered to the lung is expected to be similar for ultibro breezhaler and indacaterol monotherapy product.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kerge ja mõõduka maksakahjustusega patsientidel ei täheldatud indakaterooli cmax või auc olulisi muutusi, samuti ei erinenud valkudega seonduvus kerge ja mõõduka maksakahjustusega patsientide ning tervete kontrollisikute vahel.
patients with mild and moderate hepatic impairment showed no relevant changes in cmax or auc of indacaterol, nor did protein binding differ between mild and moderate hepatic impaired subjects and their healthy controls.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
in vitro uuringud näitasid, et ugt1a1 on ainus ugt isovorm, mille vahendusel toimus indakaterooli metabolism fenool-o-glükuroniidiks.
in vitro investigations indicated that ugt1a1 is the only ugt isoform that metabolised indacaterol to the phenolic o-glucuronide.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
hirobriz breezhalerit ei tohi kasutada patsiendid, kes võivad olla indakaterooli, laktoosi või selle ravimi mis tahes muu koostisaine suhtes ülitundlikud (allergilised).
hirobriz breezhaler must not be used in people who are hypersensitive (allergic) to indacaterol, lactose or any of the other ingredients.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
enurev breezhaler’i ja suu kaudu inhaleeritava beeta2-adrenomimeetikumi indakaterooli samaaegsel manustamisel, mõlemad toimeained olid saavutanud püsikontsentratsioonid, ei muutunud kummagi ravimi farmakokineetika.
concomitant administration of enurev breezhaler and orally inhaled indacaterol, a beta2-adrenergic agonist, under steady-state conditions of both active substances did not affect the pharmacokinetics of either medicinal product.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
inhaleeritav indakaterooli ja glükopürrooniumi kogus on vastavalt 85 mikrogrammi (vastab 110 mikrogrammile indakateroolmaleaadile) ja 43 mikrogrammi (vastab 54 mikrogrammile glükopürrooniumbromiidile).
the amount of indacaterol and glycopyrronium inhaled is 85 micrograms (equivalent to 110 micrograms of indacaterol maleate) and 43 micrograms (equivalent to 54 micrograms of glycopyrronium bromide), respectively.
Last Update: 2017-04-26
Usage Frequency: 1
Quality: